Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.97%
0%
-6.97%
6 Months
-5.87%
0%
-5.87%
1 Year
-18.7%
0%
-18.7%
2 Years
7.68%
0%
7.68%
3 Years
-22.3%
0%
-22.3%
4 Years
-19.4%
0%
-19.4%
5 Years
-12.21%
0%
-12.21%
Ion Beam Applications SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.56%
EBIT Growth (5y)
64.85%
EBIT to Interest (avg)
2.16
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.46
Sales to Capital Employed (avg)
2.84
Tax Ratio
33.28%
Dividend Payout Ratio
53.11%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
52.03%
ROE (avg)
7.89%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.91
EV to EBIT
12.57
EV to EBITDA
8.69
EV to Capital Employed
2.85
EV to Sales
0.59
PEG Ratio
0.17
Dividend Yield
NA
ROCE (Latest)
22.66%
ROE (Latest)
14.29%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
498.20
466.70
6.75%
Operating Profit (PBDIT) excl Other Income
29.00
17.90
62.01%
Interest
2.40
2.10
14.29%
Exceptional Items
-9.60
-2.10
-357.14%
Consolidate Net Profit
9.30
-9.10
202.20%
Operating Profit Margin (Excl OI)
34.80%
13.80%
2.10%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 6.75% vs 29.17% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 202.20% vs -249.18% in Dec 2023
About Ion Beam Applications SA 
Ion Beam Applications SA
Pharmaceuticals & Biotechnology
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
Company Coordinates 
Company Details
Chemin du Cyclotron 3 , LOUVAIN-LA-NEUVE None : 1348
Registrar Details






